However, it remains an investigational medicine , and more evidence is needed before it can be approved and prescribed in the UK
Plan on check-ins at about 4, 8, and 12 weeks to track weight, waist, food patterns, step count, and any side effects
18 GLP-2, also secreted by enteroendocrine L-cells, differs from GLP-1 and GIP in that it appears to have less influence on metabolic control and primarily functions as an intestinotrophic factor, helping maintain intestinal health
It enrolled 751 adults and ran for 72 weeks at the maximum tolerated dose of each drug
The gentler appetite suppression and milder side effects serve as a preview of what the medication does without the full-force impact of injectable delivery
Reminder: Microdosing remains experimental with no clinical trial validation